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Background: We recently showed that a combined deficiency of iron (ID) and n-3 fatty acids (n-3 FAD) in rats
disrupts brain monoamine metabolism and produces greater memory deficits than ID or n-3 FAD alone. Providing
these double-deficient rats with either iron (Fe) or preformed docosahexaenoic acid (DHA)/eicosapentaenoic acid
(EPA) alone affected brain monoamine pathways differently from combined repletion and even exacerbated
cognitive deficits associated with double-deficiency. Iron is a co-factor of the enzymes responsible for the
conversion of alpha-linolenic acid (ALA) to EPA and DHA, thus, the provision of ALA with Fe might be more
effective in restoring brain EPA and DHA and improving cognition in double-deficient rats than ALA alone.
Methods: In this study we examined whether providing double-deficient rats with ALA and Fe, alone or in
combination, can correct deficits in monoamine metabolism and cognition associated with double-deficiency.
Using a 2 × 2 design, male rats with concurrent ID and n-3 FAD were fed an Fe + ALA, Fe + n-3 FAD, ID + ALA, or
ID + n-3 FAD diet for 5 weeks (postnatal day 56–91). Biochemical measures, and spatial working and reference
memory (using the Morris water maze) were compared to age-matched controls.
Results: In the hippocampus, we found a significant Fe × ALA interaction on DHA: Compared to the group
receiving ALA alone, DHA was significantly higher in the Fe + ALA group. In the brain, we found significant
antagonistic Fe × ALA interactions on serotonin concentrations. Provision of ALA alone impaired working memory
compared with age-matched controls, while in the reference memory task ALA provided with Fe significantly
improved performance.
Conclusion: These results indicate that providing either iron or ALA alone to double-deficient rats affects serotonin
pathways and cognitive performance differently from combined provision. This may be partly explained by the
enhancing effect of Fe on the conversion of ALA to EPA and DHA.
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Children and adolescents from low-income countries
may suffer from both, iron (Fe) deficiency (ID) and n-3
fatty acid deficiency (n-3 FAD) due to poor quality diets
during periods of rapid growth [1,2]. Fe is a co-factor for
enzymes involved in cell division and the synthesis of
neurotransmitters, myelin and biologically active lipid
mediators and is therefore crucial for normal brain
development and functioning [3-7]. Similarly to Fe,
the long-chain polyunsaturated n-3 FA docosahexae-
noic acid (DHA, 22:6n-3) and eicosapentaenoic acid
(EPA, 20:5n-3) play important roles in neuronal growth
and differentiation, mainly by modulating physical pro-
perties of biological membranes and gene expression of
various proteins, as well as in myelination and neurotrans-
mission [8-11]. Therefore, a combined ID and n-3 FAD
occurring early in life may exert more severe effects on
brain development and functioning than an ID or n-3
FAD alone.
We have recently shown in male rats that ID and n-3
FAD in combination impairs monoaminergic neurotrans-
mission and reference memory in the Morris water
maze (MWM) to a greater extent than ID or n-3 FAD
alone [12]. In a subsequent study we repleted double-
deficient rats with Fe and a mixture of DHA and EPA,
alone and in combination, for a period of 5 weeks. We
found that the repletion with either Fe or DHA/EPA
alone affected monoamine pathways differently from
the combined repletion and, surprisingly, even exacer-
bated the working memory deficits associated with
double deficiency [13].
Approximately 35% of brain lipids occur in the form
of polyunsaturated FA, with arachidonic acid (ARA;
20:4n-6) and DHA being the main contributors [14].
The essential n-3 FA, alpha-linolenic acid (ALA), makes
up less than 1% of the brain’s lipids and thus is not con-
sidered to play a direct role in brain health [15]. Indir-
ectly, however, the intake of ALA may be crucial for
brain development and functioning via its conversion to
EPA and DHA. This might be particularly the case in
human populations who do not consume fish and who
do not have access to, or cannot afford fish oil supple-
ments. In these populations improving DHA and EPA
status by increasing the consumption of ALA-rich oils
(e.g. flaxseed, canola, and soybean oils) might be a more
suitable approach. However, tracer studies have shown
that the rate of conversion of ALA to DHA is low in
humans (1 − 5%) [16-18], but has been reported to be ef-
ficient in rats [19,20]. A recent study in rats showed that
by decreasing linoleic acid (LA; 18:2n-6) in the back-
ground diet and by keeping the total dietary polyunsa-
turated fatty acid (PUFA) intake low it is possible to
enhance the DHA status of rats fed diets containing only
ALA as a source of n-3 FA [21]. However, it is notyet known whether this finding can be extended to
the human situation. Furthermore, Fe is a co-factor
of the elongase and desaturase enzymes responsible
for the conversion of ALA to EPA and DHA [17].
Several previous rodent studies have found alterations
in blood and brain FA composition as a consequence
of ID [22-25].
Thus, the provision of ALA in combination with Fe
might be more effective in repleting brain EPA and DHA
concentrations, and in reversing the deficits associated
with n-3 FAD, than the provision of ALA alone, particu-
larly in ID subjects. Therefore, the aim of this study was
to investigate whether repleting double-deficient rats with
ALA and Fe, alone or in combination, can correct deficits
in brain monoamine metabolism and cognition associated
with deficiency.
Results
Brain weight, food intake, and body weight gain
At postnatal day (PND) 92, the body weight of ID + n-3
FAD rats was significantly lower than of age-matched
controls (p <0.001) (Table 1). Fe repletion significantly
increased total body weight gain (p <0.001) compared
to the rats receiving an ID diet and compared to con-
trols. Furthermore, compared to the rats that received
an ID diet, Fe repletion significantly increased food
intake to the level of control rats. However, body
weight at PND 92 remained lower in the experimental
groups compared to the control group (p <0.05, all
experimental groups vs. control).
Brain Fe
Brain Fe concentrations in all brain regions were signifi-
cantly lower in the ID + n-3 FAD rats than in the age-
matched controls at PND 92 (p <0.05) (Table 2). After
repletion, there was a significant effect of Fe for higher
Fe concentrations only in the olfactory bulb (OB). In the
OB, there was further an effect of ALA for higher Fe
concentrations. The Fe + ALA group had significantly
higher Fe concentrations in OB than the Fe + n-3 FAD
(p = 0.023), the ID + n-3 FAD (p = 0.010) and the ID +
ALA (p = 0.031) groups. The Fe concentrations in the
OB of Fe + n-3 FAD and ID + n-3 FAD rats remained
significantly lower than of age-matched controls. In the
frontal cortex (FC), there tended to be an Fe repletion
effect for higher Fe concentrations (p = 0.064).
Brain total phospholipid fatty acids
Repleting ID + n-3 FAD rats with ALA significantly in-
creased the relative composition of DHA and total n-3
FA in the total phospholipid fraction of the FC, OB, stri-
atum (Str) and hippocampus (Hip), while no effects were
found on EPA (Table 2). Nonetheless, DHA and total
n-3 FA composition in all four brain regions remained
Table 1 Weight gain, food intake, and brain weight of male control rats and ID + n-3 FAD rats repleted with an
Fe + ALA, ID + ALA, Fe + n-3 FAD, or ID + n-3 FAD diet for 5 wk
p Value
Control Fe + ALA ID + ALA Fe + n-3 FAD ID + n-3 FAD Fe ALA Fe × ALA
Body weight, g 409 ± 8.0 338 ± 12.5*,Δ,¥ 302 ± 7.4*,# 320 ± 7.8*,¥ 290 ± 7.1*,#,‡ 0.001 0.29 0.83
Total body weight gain, g/35d 124 ± 4.4 167 ± 9.4*,Δ,¥ 136 ± 3.8#,‡ 154 ± 4.0*,Δ,¥ 138 ± 4.3#,‡ 0.001 0.43 0.30
Total food intake, g/35d 711 ± 14.3 701 ± 26.1Δ,¥ 624 ± 12.1*,#,‡ 666 ± 12.2Δ,¥ 602 ± 9.0*,#,‡ <0.001 0.14 0.78
Relative weight gain, g/g food intake 0.17 ± 0.01 0.24 ± 0.01*,Δ 0.22 ± 0.01*,# 0.23 ± 0.00* 0.23 ± 0.00* 0.20 0.98 0.14
Values are means ± SEM, n = 8–10 per group. Abbreviations: ALA, alpha-linolenic acid; n-3 FAD, n-3 fatty acid deficient; Fe, iron; ID, iron deficient.
p Values correspond to two-way ANOVA to test effects of dietary Fe (deficient vs. sufficient) and dietary ALA (deficient vs. sufficient), and Fe × ALA interactions.
*P <0.05 versus control group, analyzed using 1-way ANOVA with diet as between-subject variable followed by post hoc Dunnett’s test to determine whether
experimental (repletion) groups differed from age-matched positive-control rats after repletion with Fe and/or ALA.
#P <0.05 versus Fe + ALA group; ΔP <0.05 versus ID + ALA group; ‡P <0.05 versus Fe + n-3 FAD group; ¥P <0.05 versus ID + n-3 FAD group; Analyzed using 1-way
ANOVA with diet (excluding control group) as between-subject variable followed by post hoc Tukey’s test to determine differences between experimental
(repletion) groups.
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groups. In the Hip, DHA and total n-3 FA were also sig-
nificantly higher in the groups receiving ALA (Fe + ALA
and ID + ALA) compared with the Fe + n-3 FAD and
the ID + n-3 FAD groups. However, there was also aTable 2 Iron concentration and major phospholipid fatty acid
rats and ID + n-3 FAD rats repleted with an Fe + ALA, ID + ALA
Control Fe + ALA ID + ALA F
Brain Fe, nmol/g tissue
FC 235 ± 11.2 210 ± 8.8 186 ± 10.5* 2
OB 300 ± 21.5 303 ± 23.0‡,¥,Δ 235 ± 9.3# 2
Str 263 ± 13.6 239 ± 14.4 223 ± 8.0 2
Hip 213 ± 6.7 192 ± 7.0 186 ± 19.8 1
Tissue fatty acids, % of total FA
20:5 n-3 (EPA)
FC 0.05 ± 0.01 0.07 ± 0.01 0.08 ± 0.02 0
OB 0.08 ± 0.01 0.10 ± 0.02 0.07 ± 0.01 0
Str 0.07 ± 0.01 0.04 ± 0.01 0.07 ± 0.01 0
Hip 0.20 ± 0.10 0.11 ± 0.02 0.10 ± 0.02 0
22:6 n-3 (DHA)
FC 13.5 ± 0.2 7.7 ± 0.2*,‡,¥ 7.7 ± 0.3*,‡,¥ 3
OB 16.0 ± 0.3 10.1 ± 0.6*,‡,¥ 9.6 ± 0.4*,‡,¥ 4
Str 14.1 ± 0.3 7.9 ± 0.3*,‡,¥ 7.6 ± 0.2*,‡,¥ 4
Hip 14.5 ± 0.6 9.7 ± 0.6*,Δ,‡,¥ 7.7 ± 0.2*,#,‡,¥ 4
Total n-3 FA
FC 14.0 ± 0.2 8.4 ± 0.3*,‡,¥ 8.6 ± 0.3*,‡,¥ 4
OB 16.5 ± 0.3 10.8 ± 0.6*,‡,¥ 10.2 ± 0.4*,‡,¥ 4
Str 14.6 ± 0.3 8.5 ± 0.3*,‡,¥ 8.3 ± 0.2*,‡,¥ 4
Hip 15.5 ± 1.0 10.6 ± 0.5*,Δ,‡,¥ 8.7 ± 0.3*,#,‡,¥ 4
Values are means ± SEM, n = 8–10 per group. Abbreviations: ALA, alpha-linolenic acid; n
ID, iron deficient; OB, olfactory bulb; Str, striatum.
p Values correspond to two-way ANOVA to test effects of dietary Fe (deficient vs. su
*P <0.05 versus control group, analyzed using 1-way ANOVA with diet as between-s
experimental (repletion) groups differed from age-matched positive-control rats aft
#P <0.05 versus Fe + ALA group; ΔP <0.05 versus ID + ALA group; ‡P <0.05 versus Fe
ANOVA with diet (excluding control group) as between-subject variable followed by postsignificant Fe × ALA interaction, indicating that in the
group receiving ALA in combination with Fe (Fe + ALA),
the relative composition of DHA and total n-3 FA was sig-
nificantly higher than in the group receiving ALA alone
(ID + ALA) (p = 0.011).composition in different brain regions of male control
, Fe + n-3 FAD, or an ID + n-3 FAD diet for 5 weeks
p Value
e + n-3 FAD ID + n-3 FAD Fe ALA Fe × ALA
08 ± 10.5 190 ± 14.7* 0.064 0.97 0.80
34 ± 12.1*,# 222 ± 18.7*,# 0.033 0.009 0.13
37 ± 14.2 204 ± 17.3* 0.12 0.26 0.62
98 ± 19.4 161 ± 11.9* 0.13 0.97 0.29
.07 ± 0.01 0.05 ± 0.01 0.60 0.43 0.23
.08 ± 0.01 0.07 ± 0.01 0.10 0.61 0.32
.06 ± 0.01 0.06 ± 0.01 0.27 0.59 0.32
.14 ± 0.03 0.09 ± 0.03 0.23 0.72 0.40
.7 ± 0.1*,#,Δ 4.0 ± 0.2*,#,Δ 0.51 <0.001 0.53
.5 ± 0.3*,#,Δ 5.2 ± 0.3*,#,Δ 0.75 <0.001 0.16
.5 ± 0.3*,#,Δ 4.3 ± 0.3*,#,Δ 0.34 <0.001 0.71
.2 ± 0.3*,#,Δ 4.7 ± 0.5*,#,Δ 0.10 <0.001 0.007
.0 ± 0.2*,#,Δ 4.2 ± 0.2*,#,Δ 0.47 <0.001 0.92
.9 ± 0.3*,#,Δ 5.6 ± 0.3*,#,Δ 0.89 <0.001 0.13
.8 ± 0.3*,#,Δ 4.7 ± 0.3*,#,Δ 0.46 <0.001 0.88
.7 ± 0.2*,#,Δ 5.2 ± 0.5*,#,Δ 0.10 <0.001 0.007
-3 FAD, n-3 fatty acid deficient; FC, frontal cortex; Fe, iron; Hip, hippocampus;
fficient) and dietary ALA (deficient vs. sufficient), and Fe × ALA interactions.
ubject variable followed by post hoc Dunnett’s test to determine whether
er repletion with Fe and/or ALA.
+ n-3 FAD group; ¥P <0.05 versus ID + n-3 FAD group; Analyzed using 1-way
hoc Tukey’s test to determine differences between experimental (repletion) groups.
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At PND 92, dopamine (DA) concentrations concentra-
tions (pmol/mg tissue) in the FC were significantly higher
in the ID + n-3 FAD group compared with the age-
matched controls (p = 0.032), while DA concentrations of
Fe + ALA, ID + ALA and Fe + n-3 FAD rats did not differ
from controls (P >0.05) (Table 3). There was a significant
effect of ALA, and an Fe × ALA interaction on serotonin
(5-HT) concentrations concentrations in the FC, indicating
that the lowering effect of ALA in combination with Fe
was attenuated when ALA was provided alone. Fe + ALA
rats had significantly higher 5-HT concentrations in the
FC than Fe + n-3 FAD rats (p = 0.025). A significant Fe ×
ALA interaction on 5-HT concentrations was also found
in the OB (P <0.05). 5-HT concentrations in the Fe + n-3
FAD rats were significantly higher than in the ID + n-3Table 3 Monoamine concentration (pmol/mg tissue) in three
FAD rats repleted with an Fe + ALA, ID + ALA, Fe + n-3 FAD, o
pmol/mg tissue Control Fe + ALA ID + ALA
DA
FC 0.19 ± 0.06 0.40 ± 0.10 0.37 ± 0.09
OB 1.28 ± 0.56 0.58 ± 0.07 0.63 ± 0.16
Str 6.87 ± 1.58 8.25 ± 2.56 9.10 ± 2.53
DOPAC
FC 2.22 ± 0.23 3.03 ± 0.50 3.25 ± 0.37
OB 2.99 ± 0.44 3.35 ± 0.35 2.99 ± 0.25
Str 12.78 ± 1.00 13.55 ± 0.87 11.97 ± 1.53
HVA
FC 1.04 ± 0.12 0.99 ± 0.21 1.29 ± 0.17
OB 2.22 ± 0.17 1.93 ± 0.19 1.90 ± 0.13
Str 16.26 ± 1.24 14.69 ± 1.14 14.19 ± 1.13
5-HT
FC 3.30 ± 0.66 1.97 ± 0.15‡ 3.93 ± 0.74
OB 2.37 ± 0.79 2.29 ± 0.50‡ 2.76 ± 0.60
Str 2.58 ± 0.66 2.74 ± 0.46 2.51 ± 0.44
5-HIAA
FC 2.31 ± 0.28 2.40 ± 0.29 1.67 ± 0.23
OB 2.16 ± 0.37 2.15 ± 0.41 2.54 ± 0.21
Str 2.48 ± 0.51 7.00 ± 1.68 5.10 ± 0.88
NE
FC 1.58 ± 0.55 1.92 ± 0.42 1.45 ± 0.43
OB 2.77 ± 0.80 3.75 ± 0.85 2.27 ± 0.32
Str 2.70 ± 0.60 3.16 ± 0.55 1.91 ± 0.36
Values are means ± SEM, n = 8–10 per group. Abbreviations: ALA, alpha-linolenic acid
acid; 5-HT, serotonin; DOPAC, dihydroxyphenylacetic acid; FC, frontal cortex; Fe, iron
bulb; Str, striatum.
p Values correspond to two-way ANOVA to test effects of dietary Fe (deficient vs. su
*P <0.05 versus control group, analyzed using 1-way ANOVA with diet as between-s
experimental (repletion) groups differed from age-matched positive-control rats aft
#P <0.05 versus Fe + ALA group; ‡P <0.05 versus Fe + n-3 FAD group; ¥P <0.05 versu
control group) as between-subject variable followed by post hoc Tukey’s test to detFAD (p = 0.039) and Fe + ALA (p = 0.049) rats, but this
increase was attenuated when Fe was provided in combin-
ation with ALA.
Morris water maze
During the cued task of the water maze, repeated-
measures ANOVA revealed a significant effect of tri-
als on distance moved (p <0.001) to reach the visible
(cued) platform, indicative of learning over the four
trials (data not shown). There was no significant ef-
fect of diet (p = 0.563), nor a significant diet × trial inter-
action (p = 0.671), indicating that sensory and motor
deficits did not affect the groups differently. Also, diet did
not affect swimming speed across trials in the cued task
(p = 0.787). However, we did find significant differences
in swimming speed between groups during the workingselected brain regions of male control rats and ID + n-3
r an ID + n-3 FAD diet for 5 weeks
p Value
Fe + n-3 FAD ID + n-3 FAD Fe ALA Fe × ALA
0.38 ± 0.07 0.55 ± 0.10* 0.46 0.36 0.31
1.02 ± 0.21 0.73 ± 0.19 0.35 0.09 0.30
6.86 ± 2.73 7.68 ± 1.58 0.40 0.74 0.88
2.28 ± 0.33 3.27 ± 0.50 0.13 0.26 0.31
2.84 ± 0.20 3.51 ± 0.36 0.54 0.88 0.13
13.67 ± 2.37 11.86 ± 0.78 0.64 0.72 0.53
1.27 ± 0.21 1.26 ± 0.22 0.44 0.56 0.37
2.12 ± 0.10 2.28 ± 0.25 0.83 0.11 0.66
15.05 ± 1.32 14.42 ± 1.00 0.72 0.82 0.96
4.67 ± 0.76# 3.36 ± 0.63 0.70 0.031 0.005
4.29 ± 0.55*,¥,# 2.22 ± 0.63‡ 0.10 0.34 0.039
1.77 ± 0.32 2.34 ± 0.52 0.67 0.15 0.38
2.28 ± 0.31 2.21 ± 0.31 0.15 0.46 0.23
1.75 ± 0.35 1.73 ± 0.27 0.42 0.16 0.26
4.09 ± 1.21 5.79 ± 1.15 0.68 0.30 0.20
2.22 ± 0.56 1.40 ± 0.32 0.14 0.76 0.78
2.02 ± 0.29 2.35 ± 0.40 0.54 0.31 0.26
3.25 ± 0.68 2.18 ± 0.39 0.05 0.72 0.71
; DA, dopamine; n-3 FAD, n-3 fatty acid deficient; 5-HIAA, hydroxyindoleacetic
; HVA, homovanillic acid; ID, iron deficient; NE, norepinephrine; OB, olfactory
fficient) and dietary ALA (deficient vs. sufficient), and Fe × ALA interactions.
ubject variable followed by post hoc Dunnett’s test to determine whether
er repletion with Fe and/or ALA.
s ID + n-3 FAD group; Analyzed using 1-way ANOVA with diet (excluding
ermine differences between experimental (repletion) groups.
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significantly higher than of ID + ALA (p = 0.042) and ID +
n-3 FAD rats (p = 0.011). Even though not reaching
significance, a similar pattern was also seen during the ref-
erence memory task. Therefore, we analyzed working me-
mory and reference memory by using distance moved
(in cm) to find the hidden platform and not by escape la-
tency (in s), which could be confounded by between-
group differences in swimming speed.
During the working memory task, there was a signifi-
cant effect of trials and days on mean distance moved
(trials: p <0.001; days: p <0.001) to find the hidden plat-
form (Figure 1A), indicating that overall learning and
memory took place across trials and days. There was
no significant effect of diet nor a diet × trial interaction.
Separate 2 × 2 repeated-measures ANOVA to investigate
the effects of Fe and ALA repletion (excluding the con-
trol group), revealed a trend towards an effect of Fe re-
pletion for shorter distance moved to find the hidden
platform in the working memory task (p = 0.061). Fur-
thermore, ID + ALA rats tended to swim a longer distance
to reach the hidden platform during trial 2 compared to
age-matched controls (p = 0.051). Working memory is
typically reflected in a rapid reduction of distance moved
from trial 1 (when platform position is unknown) to trial
2. Therefore, we calculated the difference in distance
moved between trial 1 and trial 2 across all 4 days
(Figure 1B). The difference in distance moved between
trial 1 and trial 2 was significantly lower in ID +ALA rats
compared to age-matched controls (p <0.05), indicating
impaired working memory.
During the reference memory trial, there was a sig-
nificant effect of days and trials, as well as a significant
diet x trial interaction (p = 0.045) on distance moved,Figure 1 Working memory task in the Morris water maze (MWM). Wo
ID + n-3 FAD rats repleted with an Fe + ALA, ID + ALA, Fe + n-3 FAD, or an
reach hidden platform located at different positions across 4 days, with 4 t
performance expressed as difference in distance moved between trial 1 an
n-3 FAD, n-3 fatty acid deficient; Fe, iron; ID, iron deficient.indicating that not all diet groups showed an improve-
ment in distance moved to find the hidden platform
across the 4 trials (Figure 2A). Separate analyses of the
distances moved from day 1 to 4 for each diet group re-
vealed that there was no significant improvement in dis-
tance moved from day 1 to day 4 (day: p >0.05) in the
ID + ALA and Fe + n-3 FAD groups, while there was
a significant improvement in the Fe + ALA (p <0.001),
ID + n-3 FAD (p <0.026) and control (p <0.001) groups.
Furthermore, there was a significant effect of ALA reple-
tion for shorter overall distance moved to find the hidden
platform (p = 0.025) (Figure 2B). The Fe + ALA group, but
not the ID + ALA group, swum a significantly shorter dis-
tance to find the hidden platform than the Fe + n-3 FAD
(p = 0.048) and ID + n-3 FAD (p = 0.049) groups.
After 4 days of reference trials, the platform was re-
moved and the rats were subjected to a probe trial. The
percent distance the repletion groups spent in the tar-
get quadrant did not significantly differ from controls
(Figure 3). However, the ID + n-3 FAD rats tended to
spend a shorter distance in the target quadrant than the
controls (p = 0.077). Only the control and ID +ALA rats
showed a distinct preference for the target quadrant, indi-
cated by percent distance spent in target quadrant being
significantly above chance level (25%) (Control, p = 0.017;
ID + ALA, p = 0.020).
Discussion
This is the first study, to our knowledge, to investigate
the effects of repleting male adult rats deficient in Fe
and n-3 FA with ALA and Fe, alone and in combination,
on brain monoamine concentrations and cognitive per-
formance. The experimental model was chosen to reflect
the common scenario in low-income countries whererking memory performance in the MWM of male control rats and
ID + n-3 FAD diet for 5 weeks. (A) Mean distance moved per trial to
rials per day in the working memory task; (B) working memory




Figure 2 Reference memory task in the Morris water maze (MWM). Reference memory performance in the MWM of male control and
ID + n-3 FAD rats repleted with an Fe + DHA/EPA, ID + DHA/EPA, Fe + n-3 FAD, or an ID + n-3 FAD diet for 5 weeks. (A) Mean distance moved per
day to reach hidden platform located at same positions across 4 days, with 4 trials per day in the reference memory task; (B) Mean overall
distance moved in the reference memory task. Values are means ± SEM, n = 7–8. #P <0.05 versus Fe + ALA group. ‡P <0.05 versus Fe + n-3 FAD
group. ¥P <0.05 versus ID + n-3 FAD group. ALA, alphal-linolenic acid; n-3 FAD, n-3 fatty acid deficient; Fe, iron; ID, iron deficient.
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sume a diet low in Fe and n-3 FA throughout childhood
and only begin to consume a diet sufficient in one or
both nutrients in early adulthood as dietary quality and
variety improves.
The provision of ALA to ID + n-3 FAD rats for 5 weeks
(PND 56–91) significantly increased the relative com-
position of DHA in total phospholipid FA of different
brain regions to ~ 50 − 70% of control values. In contrast,
the provision of Fe resulted in near complete recovery of
brain Fe (~90–100% of controls). In the Hip, the syner-
gistic Fe × ALA interaction for higher DHA levels mayFigure 3 Probe trial. Percentage of total distance spent in the
target quadrant during the probe trial, when the platform was
removed and the rats were allowed to swim freely for 60 s. There
were no differences in total distance and time spent in the target
quadrant between groups. #Indicates groups that performed above
chance level (25%) in the target quadrant; p <0.05. Values are
means ± SEM, n = 7–8. ALA, alpha-linolenic acid; n-3 FAD, n-3 fatty
acid deficient; Fe, iron; ID, iron deficient.be explained by Fe being a co-factor of hepatic de-
saturases and elongases, which are responsible for the
conversion of ALA to EPA and DHA [26,27]. Thus, pro-
viding ALA in combination with Fe to double-deficient
rats might enhance the conversion of ALA into its re-
spective long-chain derivative DHA. Whether this fin-
ding can be translated to the human situation is not
clear, as previous studies have shown that, in contrast to
humans, the conversion of ALA to EPA and DHA is
more efficient in rats [19,20]. Nevertheless, Smuts et al.
showed that providing ID school children with iron-
fortified soup not only improved Fe but also n-3 FA
status [18].
Rats that remained ID during the depletion period
showed a ~15% reduction in food intake, which was also
reflected by ~15% lower body weight compared to the
groups repleted with Fe. This is consistent with several
previous studies reporting decreased food intake associ-
ated with poor growth in rats suffering from ID anaemia
[12,28-30]. However, previous depletion studies showed
that severe ID decreased relative weight gain (g weight
gain per g food intake) [12,28], while in the current stu-
dy, relative weight gain was the same in rats repleted
with Fe and remaining ID. Since neurotransmitters, in-
cluding DA and 5-HT, are involved in the regulation of
food intake [31], it is possible that the reduced food in-
take of ID rats is related to alterations in monoaminergic
neurotransmission. Also, the reduced body weight in ID
rats may explain why swimming speed in the MWM was
lower in ID + ALA and ID + n-3 FAD rats.
We previously showed that the provision of an ID + n-3
FAD diet for 5 weeks post-weaning resulted in an additive
1- to 2-fold increase in DA concentrations in the OB
and Str, and decreased 5-HT concentrations relative to
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at PND 91, rats that remained ID + n-3 FAD had signifi-
cantly higher DA concentrations than controls (+189%) in
the FC. In contrast, DA concentrations in rats that re-
ceived ALA and Fe, alone or in combination, did not differ
from controls, consistent with our previous study in which
DHA/EPA was provided alone and in combination with
Fe [13]. However, in contrast to our previous study, where
we found a significant Fe ×DHA/EPA interaction on the
DA metabolite dihydroxyphenylacetic acid (DOPAC) in
the OB and Str [13], we found no Fe × ALA interactions
on DOPAC in the current study. However, we did find sig-
nificant antagonistic Fe × ALA interactions on 5-HT in
FC and OB, which suggest that the provision of Fe in
combination with ALA to double-deficient rats affects
5-HT concentrations differently from the provision of Fe
and ALA alone. The FC is one of the last brain areas to
become fully mature and previous studies have reported
dramatic increases in DA- and 5-HT-mediated neuro-
transmission in the FC during adolescence [32-34]. This
may explain why most effects of Fe and ALA repletion
and of continued ID + n-3 FAD depletion at PND 91 were
observed in the FC. Several rodent studies have previously
investigated whether alterations in monoaminergic neuro-
transmission caused by ID can be reversed by Fe repletion
[35-40]. These studies varied in timing and severity of ID,
in timing and dose of iron repletion, as well as in the brain
regions observed. Generally, the effects of ID induced dur-
ing gestation and pre-weaning have been shown to be per-
sistent [35,36,39,40]. Rodent studies using a model of
post-weaning ID are limited. To our knowledge, to date,
only one study has shown that alterations in extracellular
DA in the caudate putamen caused by ID introduced
post-weaning were mostly reversible by iron repletion
[41]. Also, few studies have investigated whether the detri-
mental effects of n-3 FAD (induced over two generations)
on monoaminergic neurotransmission can be reversed
with ALA repletion [42,43]. Kodas et al. investigated syn-
aptic levels of DA and 5-HT in basal conditions and after
pharmacological stimulation in rats that were n-3 FA de-
pleted and in rats that were repleted with an ALA suffi-
cient diet starting at different time points (birth, PND 7,
PND 14 or PND 21) [42,43]. N-3 FA deficiency altered
DA and 5-HT release in basal conditions and under sti-
mulation in the rat Hip. The provision of ALA during the
first two weeks of postnatal life reversed these alterations,
while they persisted in rats that received the repletion diet
only from PND 21.
Nonetheless, our results cannot be directly compared
with the results of these studies, as the experimental rats
in our study were deficient in both Fe and n-3 FA before
receiving the repletion diets. Thus, the effects of Fe or
n-3 FA repletion could have been confounded by the un-
treated deficiency. It is well known that neurotransmittersystems can adapt to chronic stressors, such as drug and
alcohol exposure [44]. This could explain why certain
monoamines that were altered in the ID + n-3 FAD rats
after the depletion study (PND 56) were no longer al-
tered in the rats that remained ID + n-3 FAD during the
repletion study (at PND 92). We speculate that provid-
ing double-deficient rats with one nutrient only affects
the adapted system differently than the provision of both
nutrients, e.g. by re-activating different mechanisms,
which may explain the different effects on brain 5-HT
concentrations when Fe and ALA were provided alone
and in combination.
Disturbances in DA and 5-HT neurotransmission can
impair learning and memory [45]. The results from the
MWM testing indicate that the provision of ALA alone
to double-deficient rats significantly impairs working
memory performance compared to age-matched con-
trols. This finding is consistent with our previous study,
where the provision of DHA/EPA alone also produced
significant deficits in working memory performance com-
pared to age-matched controls [13]. The mechanism of
this effect is uncertain. Spatial working memory is mainly
hippocampal-dependent but is sub-served in part by the
prefrontal cortex [45,46]. Therefore, the working memory
results might be explained by the differential effects of
ALA on 5-HT in the FC when provided alone and in com-
bination with Fe. There is evidence suggesting that 5-HT
is involved in working and reference memory processes
[45,47]. Unfortunately, data on monoamine concentra-
tions in the Hip are not available in the current study.
We consistently demonstrated that rats repleted with
ALA or Fe alone showed no learning effect in the refe-
rence memory task, indicated by a lack of improvement
in distance swum across trials and days to find the hid-
den platform. On the other hand, rats that received ALA
in combination with Fe exhibited a marked improve-
ment. This finding could again be attributed to the dif-
ferential effects of ALA and Fe on 5-HT concentrations
in the FC when provided alone or in combination. Con-
sistently, a recent study reported that ID rats fed with Fe
and a mixture of essential FA, containing equal amounts
of LA and ALA, exhibited improved learning and mem-
ory performance in the MWM compared with controls,
while the rats fed with Fe alone performed worse [48].
In contrast to our previous study that provided DHA/
EPA, alone and in combination [13], we did find that the
provision of ALA significantly shortened overall distance
moved to find the hidden platform during the reference
memory task. However, this beneficial effect of ALA was
only apparent in the Fe + ALA group, which swam a sig-
nificantly shorter distance to find the platform than the
groups that remained double-deficient or received Fe or
ALA only. Since spatial learning and memory tested in
the MWM is mainly hippocampus-dependent [49,50],
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pholipid FA in the Hip of rats that were fed ALA in
combination with Fe might explain the improved rever-
ence memory performance in this group. Nevertheless,
it may be that ALA exerted beneficial effects on cogni-
tive performance independent of its conversion to EPA
and DHA.
Since spatial working and reference memory is mainly
hippocampal-dependent, it is a limitation of this study
that monoamine concentrations were not analyzed in
the Hip. Also, the assessment of other neurotransmit-
ters, such as glutamate and gamma-aminobutyric acid,
or other factors involved in learning and behaviour, such
as myelination, neuronal inflammation, and processes
of morphogenesis and cell growth, would have been
valuable.
Conclusion
Consistent with our previous study in which a mixture
of DHA/EPA was provided, alone and in combination
with Fe, feeding either ALA or Fe alone to adult rats
with both ID and n-3 FAD affected brain 5-HT concen-
trations differently from the provision of ALA and Fe in
combination, and even exacerbated the working memory
deficits associated with combined deficiency. However,
in contrast to our previous study, the provision of ALA
had a beneficial effect on reference memory, particularly
when provided in combination with Fe, which may be
explained by the enhancing effect of Fe on the conver-
sion of ALA to DHA in the Hip. These findings are of
relevance to human populations, as many children fromFigure 4 Flow diagram of the experimental design. n indicates the num
parts of the experiment were done at a commercial animal breeding cente
ID, iron deficient.a low-socioeconomic background may suffer from both
ID and n-3 FAD due to poor quality diets. Furthermore,
in populations with a low fish intake, improving DHA
and EPA status by increasing the consumption of ALA-
rich oils (e.g. flaxseed, canola or soybean oils) might be a
more suitable approach. Our results indicate that in such
populations, it may be crucial to provide ALA-rich oils
and foods in combination with Fe.
Methods
Rats and diets
All experimental procedures were approved by the
Veterinary Office of the Department of Health of the
Canton of Zürich. Male Wistar rats were first made
n-3 FAD over two generations. Male rats were chosen to
avoid potential confounding effects of estrogen that have
been reported in previous studies of ID and n-3 FAD
[51,52]. At a commercial animal breeder (RCC), female
Wistar rats (PND 21) were fed an n-3 FAD diet (detailed
below), and were mated at 11 weeks with 12-week-old
male breeders of the same strain. After the mating period,
the females continued to consume the n-3 FAD diet and
the rat pups were kept with their dams until weaning.
After weaning at PND 21, male n-3 FAD rats received a
concurrent ID and n-3 FAD (ID + n-3 FAD) diet for a de-
pletion period of 5 weeks. At PND 56, the now ID + n-3
FAD rats (n = 39) were randomly divided into four groups
(Figure 4). The repletion study was designed as a 2 × 2 fac-
torial experiment and the four groups received the follow-
ing diets for a period of 5 wk: 1) a continued ID and n-3
FAD (ID + n-3 FAD, n = 10); 2) Fe replete and n-3 FADbers in each experimental group. Boxes in dashes indicate that these
r. ALA, alpha-linolenic acid; n-3 FAD, n-3 fatty acid deficient; Fe, iron;
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n = 10); or 4) ID and ALA replete (ID + ALA, n = 10) diet.
Furthermore, we included an age-matched (positive-) con-
trol group from dams that received the n-3 FA and Fe suf-
ficient basal AIN-93G diet.
The purified experimental diets were obtained com-
mercially (Dyets, Bethlehem, PA, USA) and were based
on the AIN-93G [53] formulation with modifications in
Fe content and fat source (Table 4). All diets contained
10% fat. The n-3 FAD diets contained hydrogenated co-
conut oil at 81 g/kg diet, and safflower oil at 19 g/kg
diet. The ALA repletion diets contained hydrogenated
coconut oil at 60 g/kg diet, safflower oil at 32 g/kg diet
and flaxseed oil at 8 g/kg diet. All diets included n-6 FA
in the form of LA. The Fe replete diets contained 35 mg
Fe/kg, and the ID diets during the preceding depletion
period of 5 weeks contained 3 mg Fe/kg. For the reple-
tion period, the Fe dose in the ID diets was increased to
10 mg Fe/kg diet in order to avoid potential deaths from
prolonged severe ID anemia. All diets were custom pre-
pared in powdered form to avoid lipid oxidation during
pelletization, vacuum packed in bags of 2 kg, and stored
at −20°C until use.Table 4 Composition of experimental diets during
depletion period*
Ingredient g/kg diet












n-3 FAD† ALA sufficient‡ Control¥
Coconut oil (hydrogenated) 81.0 60.0 30.0
Soybean oil 0.0 0.0 70.0
Safflower oil 19.0 32.0 0.0
Flaxseed oil 0.0 8.0 0.0
*Experimental diets were based on the AIN-93G formulation with modifications
in iron content and fat source.
#The mineral mix provided 35 mg iron/kg diet in the iron sufficient diets and
3 mg iron/kg diet in the iron deficient diets. n-3 FAD, n-3 fatty acid deficient;
ID, iron deficient; TBHQ, t-butylhydroquinone.
†Providing approximately 15.1 g/kg diet linoleic acid (LA) and 0.04 g/kg diet
α-linolenic acid (ALA).
‡Providing approximately 20.0 g/kg diet LA and 46.0 g/kg diet ALA.
¥AIN-93G formulation providing approximately 35.7 g/kg diet LA and 4.8 g/kg
diet ALA.Tissue collection
At the end of the repletion period (PND 91 and 92) rats
were exposed to CO2 to introduce unconsciousness for
blood collection by cardiac puncture and then killed by
decapitation. The brains were rapidly removed and OB,
FC, Str and Hip were isolated from both hemispheres by
freehand dissection. Brain regions were placed into pre-
weighed Eppendorf tubes, their wet weight was recorded
and then they were snap-frozen in liquid nitrogen and
stored at −80°C. Per brain area, tissues obtained from
the left and right hemispheres were alternately used for
the analysis of brain iron and FA content.Brain iron analysis
Brain regions were homogenized and digested with nitric
acid according to Erikson et al. [54], and total Fe con-
centrations measured using graphite furnace atomic
absorption spectrometry (AAS; Perkin Elmer AA400,
Beaconsfield, Bucks, UK) as described previously [12].Total phospholipid fatty acid analysis
Lipids were extracted from each brain region with chlo-
roform:methanol (2:1 v/v) by a modification of the
method of Folch et al. [55]. The lipid extracts were con-
centrated and the neutral lipids separated from the phos-
pholipids by thin-layer chromatography (TLC) (Silica gel
60 plates, 10 x 20 cm, Merck, Darmstadt, Germany) and
eluted with diethyl ether: petroleum ether: acetic acid
(30:90:1 v/v/v). The lipid band containing phospholipids
was removed from the TLC plate and transmethylated
with methanol:sulphuric acid (95:5 v/v) at 70°C for 2 h to
yield fatty acid methyl esters (FAME). The resulting
FAME was extracted with water and hexane. The organic
layer was evaporated, re-dissolved in hexane and analyzed
by QP GC-EI-MS on an Agilent Technologies 7890A GC
system equipped with an Agilent Technologies 5975C VL
mass selective detector. The GC separation of FAME was
carried out on an HB-5MS capillary column (30 m ×
0.250 mm × 0.25 μm; Agilent J&W) using helium as the
carrier gas at a flow rate of 0.9 mL/min. The GC injector
was held at a temperature of 250°C and the MS source
and QP were maintained at temperatures of 230°C and
150°C respectively. The injection volume of the sample so-
lution was 1 μL, using a split ratio of 1:25 for the brain
samples. The oven temperature started at 140°C and was
programmed at +3°C/min from 140 to 220°C, held at
220°C for 2 min, then programmed at +3°C/min to 230°C
and held at 230°C for 10 min. Total analysis time was
45 min. Mass spectrometry with 70 eV EI was carried out
in full scan acquisition mode and all mass spectra were ac-
quired over the m/z range of 50–750. Quantification of
FAME was done using the selected ion extraction (SIE)
method.
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mixture of 26 FAME (Nu-Check-Prep, Elysian, MN) and
three single FAME standards (Larodan Fine Chemicals
AB, Malmö, SE) were injected at equal concentrations
ranging between 1 and 400 ng in 1 μL and calibration
plots for each FAME were obtained using peak areas
from mass chromatograms, using C17:0 as an external
standard. Data analysis was performed using MSD Chem
Station software (Agilent G1701EA version E.02.00.493).
Relative percentages of FA were calculated by taking
the concentration of a given FA derivative as a per-
centage of the total concentration of all FA identified
in the sample.
Brain monoamine analysis
DA dihydroxyphenylacetic acid (DOPAC), homovanillic
acid (HVA), 5-HT, 5-hydroxyindoleacetic acid (5-HIAA)
and norepinephrine (NE) were measured in Str, FC and
OB using reverse-phase HPLC with electrochemical
detection. Several previous rodent studies have shown that
monoaminergic neurotransmission in these brain regions
was affected by ID and/or n-3 FAD [35,36,43,56-58]. We
initially also planned to measure monoamine concentra-
tions in the Hip. However, unfortunately the Hip samples
got lost during shipment to the analytical laboratory. The
regions were prepared and analyzed as described else-
where with minimal modifications [7,41]. Briefly, 1 g of
tissue was diluted into 10 mL PBS spiked with complete
protease inhibitor tablets (Roche Diagnostics, Mannheim,
Germany). Samples were homogenized on ice with a PT
1200E Polytron tissue homogenizer using acid washed
plastic dispersing-aggregates (single use; Kinematic AG,
Littau, Switzerland). Homogenates were then passed 10
times through a 1 mL insulin syringe with 29G × 12.7 mm
needle (Beckton Dickinson AG, Allschwil, Switzerland) to
further homogenize the tissue. Homogenates were soni-
cated with 5 up and down strokes. 50 μL of the hom-
ogenate were added to 50 μL 0.24 M HClO4. 10 μL
internal standard (dihydroxybenzylamine, 1.1 mg/L) was
added to track efficiency of extraction in all samples.
The spiked solution was sonicated for 10 s, filtered
using Costar Spin-X filter tubes 0.2 μm (Corning, NY,
USA), and 10 μL was injected onto the HPLC by an
ESA 542 refrigerated auto sampler, as described by
Bianco et al. [7].
Morris water maze test
The MWM was used to evaluate spatial learning and
memory performance. The MWM test was carried out
in the dark phase of the cycle in eight randomly selected
rats from the experimental groups and from the control
group. The maze consisted of a black, circular, fiberglass
tank (2 m in diameter) that was positioned in the middle
of a testing room enriched with unique distal spatialcues under dim lighting condition (12 lux as measured
from the maze centre). The tank was filled daily with
fresh tap water (22 ± 1°C) to a depth of 30 cm. A black,
circular platform (11 cm in diameter) submerged 1.5 cm
below the water surface was used as an escape platform
invisible to the rats. All trials were monitored by a video
camera installed above the water maze, and analyzed
using Ethovision software version 3.1 (Noldus).
The rats underwent four phases of testing in the water
maze on 10 consecutive days: 1) Cued task (1 d, PND
80); 2) Working memory task (4 d, PND 81–84); 3) Re-
ference memory task (4 d, PND 85–88) and; 4) Probe
test (1 d, PND 89).
First, the rats were familiarized to the water maze pro-
cedure in a cued task, which also served as a test for non-
specific sensory motor differences. In this pre-training
phase, the platform was positioned in the center of the
maze and was made visible with a local cue (flag). Each rat
underwent 4 consecutive trials, with the starting position
randomly selected from four release points (N, W, S,
and E). Each rat was released into the water facing the
outer edge of the pool and was allowed a maximum of
90 s to escape onto the platform. If a rat failed to do so, a
maximum escape latency of 60 s was recorded, and the rat
was guided to the platform by the experimenter and
allowed to stay on it for an inter-trial interval of 15 s be-
fore the next trial.
The next day, in the working memory task, the plat-
form position (randomized across rats) varied from one
day to the next in a non-repetitive manner, but remained
submerged, but without the local cue, at the same pos-
ition across the four trials within a day. The four plat-
form positions were 16 cm off the wall in the NW, NE,
SE and SW directions of the tank. The starting positions
varied randomly across the trials amongst the four pos-
sible release points (N, W, S and E). The rats were allowed
90 s to find the platform and the inter-trial interval was
15 s. This task taxes the flexible use of day-dependent
short-term (working) memory [59]. As previously, when a
rat failed to locate the platform within 90 s, it was guided
to it and a maximum escape latency of 60 s was recorded.
The reference memory task began the day after com-
pletion of the working memory task. This task assessed
long-term spatial memory, by applying a procedure in
which the platform remained in a constant location
across trials (4 trials per day) and across training days
(4 days), while the starting positions changed randomly
across trials. As described above, the rats were allowed
to search for the platform for 90 s, with an inter-trial
interval of 15 s.
A probe test was conducted 24 h after the final refe-
rence trial to assess memory retention. To this end, the
platform was removed from the tank and the rats were
released in the quadrant opposite to the trained platform
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water maze for 60 s (one trial only). The distance cov-
ered in each quadrant was recorded.
After each training day in the water maze, the rats
were dried under a red-light heat lamp, before being re-
turned to their home cages.Statistical analysis
Data were analyzed using IBM SPSS Statistics software
(version 20.0). Data were examined for normality of dis-
tribution by a Shapiro-Wilk test and the presence of out-
liers (±3 SD from the mean, boxplots). Homogeneity of
variance was examined by Levene’s test. Datasets that
significantly deviated from normality and/or variance ho-
mogeneity were transformed prior to interferential statis-
tical analysis using ANOVA.
This repletion study was designed as a 2 × 2 factorial
experiment. Figure 1 shows that the control group did
not have the same dietary history as the repletion groups.
The control group was used as a positive-control to exa-
mine whether repletion with either nutrient alone or
in combination can reverse deficits in cognition and
changes in biochemical indicators associated with double-
deficiency to a level of age-matched rats that received an
n-3 FA and Fe sufficient basal AIN-93G diet throughout
their lives. Therefore, we performed two different statis-
tical analyses with the following aims: 1) 2-way ANOVA
for biochemical indicators and 2-way repeated measures
ANOVA (with trials and days as repeated measurement
variables) for MWM data, excluding the control group, to
determine the effects of Fe (sufficient vs. deficient) and
ALA (sufficient vs. deficient) repletion and their interac-
tions in double-deficient rats. Tukey’s tests (Fisher’s least
significant difference tests for MWM data) were used for
appropriate pair-wise comparison following the emer-
gence of significant effects from the overall ANOVA. Sig-
nificant treatment effects in the absence of a significant
interaction effect indicated additive effects of the treat-
ments, whereas a significant interaction implied synergism
or antagonism; 2) 1-way ANOVA with diet as between-
subject variable followed by post hoc Dunnett’s test to de-
termine whether experimental (repletion) groups differed
from age-matched positive-control rats after repletion
with Fe and/or ALA.
For the MWM probe trial, the percentage distance and
time spent in the target quadrant were compared between
groups using 1-way ANOVA with diet as between-subject
variable followed by Fisher’s least significant difference
tests. Furthermore, one-sample t-tests were carried out to
investigate whether distance moved in the target quadrant
was above the chance level of 25%. The results were ex-
pressed as means ± SEM and differences were considered
significant at p <0.05.Abbreviations
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